An immune cocktail therapy to realize multiple boosting of the cancer-immunity cycle by combination of drug/gene delivery nanoparticles
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An immune cocktail therapy to realize multiple boosting of the cancer-immunity cycle by combination of drug/gene delivery nanoparticles
Authors
Keywords
-
Journal
Science Advances
Volume 6, Issue 40, Pages eabc7828
Publisher
American Association for the Advancement of Science (AAAS)
Online
2020-10-01
DOI
10.1126/sciadv.abc7828
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Top 10 Challenges in Cancer Immunotherapy
- (2020) Priti S. Hegde et al. IMMUNITY
- Highly efficient and tumor-selective nanoparticles for dual-targeted immunogene therapy against cancer
- (2020) Kuan-Wei Huang et al. Science Advances
- A disassembling strategy overcomes the EPR effect and renal clearance dilemma of the multifunctional theranostic nanoparticles for cancer therapy
- (2019) Yanbing Wang et al. BIOMATERIALS
- Tumor microenvironment as the “regulator” and “target” for gene therapy
- (2019) Jiayan Wu et al. JOURNAL OF GENE MEDICINE
- Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial
- (2019) Leonie Voorwerk et al. NATURE MEDICINE
- Delivery of nitric oxide with a nanocarrier promotes tumour vessel normalization and potentiates anti-cancer therapies
- (2019) Yun-Chieh Sung et al. Nature Nanotechnology
- Red blood cell–derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy
- (2019) Xiao Han et al. Science Advances
- Combination Cancer Therapy with Immune Checkpoint Blockade: Mechanisms and Strategies
- (2018) Shetal A. Patel et al. IMMUNITY
- Macrophage targeting: opening new possibilities for cancer immunotherapy
- (2018) Luca Cassetta et al. IMMUNOLOGY
- Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap
- (2018) Wantong Song et al. Nature Communications
- Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses
- (2017) Abhishek D. Garg et al. IMMUNOLOGICAL REVIEWS
- Effector CD8 T cells dedifferentiate into long-lived memory cells
- (2017) Ben Youngblood et al. NATURE
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- Recent progress in cationic polymeric gene carriers for cancer therapy
- (2017) Caina Xu et al. Science China-Chemistry
- Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression
- (2017) Jianqin Lu et al. Nature Communications
- PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
- (2017) Hashem O. Alsaab et al. Frontiers in Pharmacology
- Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy
- (2016) Christina Pfirschke et al. IMMUNITY
- Acid-Activatable Versatile Micelleplexes for PD-L1 Blockade-Enhanced Cancer Photodynamic Immunotherapy
- (2016) Dangge Wang et al. NANO LETTERS
- Ultrasensitive pH Triggered Charge/Size Dual-Rebound Gene Delivery System
- (2016) Xiuwen Guan et al. NANO LETTERS
- Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade
- (2016) K. E. Pauken et al. SCIENCE
- Cisplatin-loaded polymeric nanoparticles: Characterization and potential exploitation for the treatment of non-small cell lung carcinoma
- (2015) Chunshan Shi et al. Acta Biomaterialia
- PD-1 blockade in tumors with mismatch repair deficiency.
- (2015) Dung T. Le et al. JOURNAL OF CLINICAL ONCOLOGY
- Lung cancer is associated with decreased expression of perforin, granzyme B and interferon (IFN)-γ by infiltrating lung tissue T cells, natural killer (NK) T-like and NK cells
- (2014) G. Hodge et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Nanoscaled Poly(l-glutamic acid)/Doxorubicin-Amphiphile Complex as pH-responsive Drug Delivery System for Effective Treatment of Nonsmall Cell Lung Cancer
- (2013) Mingqiang Li et al. ACS Applied Materials & Interfaces
- Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer
- (2012) Michael A Jacobetz et al. GUT
- Therapeutic Targeting of Hyaluronan in the Tumor Stroma
- (2012) Anne Kultti et al. Cancers
- Hyaluronidase and Collagenase Increase the Transfection Efficiency of Gene Electrotransfer in Various Murine Tumors
- (2011) Maja Cemazar et al. HUMAN GENE THERAPY
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- ECM components guide IL-10 producing regulatory T-cell (TR1) induction from effector memory T-cell precursors
- (2011) P. L. Bollyky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Altered hyaluronan biosynthesis in cancer progression
- (2008) Naoki Itano et al. SEMINARS IN CANCER BIOLOGY
- Hyalurondiase: Both a tumor promoter and suppressor
- (2008) Vinata B. Lokeshwar et al. SEMINARS IN CANCER BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started